News Archive

EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 November 2022

15th November 2022

EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 November 2022

Read More+

EMA - Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 November 2022

15th November 2022

EMA - Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 November 2022

Read More+

MHRA - Information about procurement at the Agency

15th November 2022

Procurement at MHRA - Information about procurement at the Agency and how they are improving procurement opportunities for small and medium-sized enterprises.

Read More+

MHRA - Return to International GMP Inspections

15th November 2022

MHRA - Return to International GMP Inspections

Read More+

EDQM - All new European Pharmacopoeia (Ph. Eur.) texts and texts that have undergone technical revisions are published in Pharmeuropa for public consultation. The deadline for comments on Pharmeuropa 34.4 is 31 December 2022.

19th October 2022

All new European Pharmacopoeia (Ph. Eur.) texts and texts that have undergone technical revisions are published in Pharmeuropa for public consultation. The deadline for comments on Pharmeuropa 34.4 is 31 December 2022.

Read More+

EMA - High-quality data to empower data-driven medicines regulation in the European Union

19th October 2022

High-quality data to empower data-driven medicines regulation in the European Union.

Read More+

EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2022

19th October 2022

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2022

Read More+

EMA - Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 2022

19th October 2022

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 2022

Read More+

EMA - Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022

19th October 2022

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022

Read More+

ICH - Q5A(R2) draft Guideline on Viral Safety Evaluation of Biotechnology Products reached Step 2

19th October 2022

The ICH Q5A(R2) draft Guideline on Viral Safety Evaluation of Biotechnology Products reached Step 2 of the ICH process on 29 September 2022.

Read More+